“Big data” gets personal
暂无分享,去创建一个
[1] Mick P Couper,et al. Design, methods, and participant characteristics of the Impact of Personal Genomics (PGen) Study, a prospective cohort study of direct-to-consumer personal genomic testing customers , 2014, Genome Medicine.
[2] Patrick F. Sullivan,et al. Quantifying prion disease penetrance using large population control cohorts , 2016, Science Translational Medicine.
[3] Isaac S Kohane,et al. The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine , 2014, Trials.
[4] E. Minikel,et al. Ascertainment bias causes false signal of anticipation in genetic prion disease. , 2014, American journal of human genetics.
[5] R. Green,et al. Consumers report lower confidence in their genetics knowledge following direct-to-consumer personal genomic testing , 2015, Genetics in Medicine.
[6] Matthew S. Lebo,et al. A systematic approach to the reporting of medically relevant findings from whole genome sequencing , 2014, BMC Medical Genetics.
[7] Matthew S. Lebo,et al. Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity , 2015, Genetics in Medicine.
[8] Robert Cook-Deegan,et al. Disclosure of APOE genotype for risk of Alzheimer's disease. , 2009, The New England journal of medicine.
[9] Michael Krawczak,et al. Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease , 2013, Human Genetics.
[10] Tan Ru San,et al. Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease , 2015, Science Translational Medicine.